PTSD - Post Traumatic Stress Disorder study: Present-Centered Therapy
Official title Trial of Acceptance and Mindfulness-based Exposure Therapy (AMBET) and Present Centered Therapy (PCT)
ClinicalTrials.gov ID: NCT07410481
What this study is testing
- What it's testing
- This study aims to find out if Acceptance- and Mindfulness-Based Exposure Therapy (AMBET) reduces PTSD symptoms. It also compares AMBET to another therapy called Present Centered Therapy (PCT) to see which is more effective.
- Who it's for
- The study is looking for people who have survived a cardiac arrest and are living with PTSD.
- What's involved
- Participants will be randomly assigned to receive either AMBET or PCT. They will attend 12 hours of individual therapy sessions, complete weekly online surveys, wear a Fitbit to track sleep and activity, and do brief homework assignments.
- Time commitment
- The study lasts about 12 weeks and requires attending individual therapy sessions and completing weekly online tasks.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 81
You may be able to join if
- Between 18 and 81 years old at the time of consent
- Fluency in English
- Medical history of cardiac arrest \>3 months ago
- Clinically elevated PTSD symptoms (Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) score ≥25)
- U.S. Resident
You likely can't join if
- Lifetime history of primary psychotic or bipolar disorders
- Current substance use disorder (moderate or severe in the past 6 months)
- Active suicidal ideation with some intent to act in past 12 months, and/or suicide attempt in past 24 months
- Substantial cognitive impairment (Mini Mental Status Exam (MMSE) score \<25)
- Initiation of new psychotropic medication \<3 months ago
- Non-cardiac etiology of CA (drowning, bleeding, trauma, drug overdose, etc)
See the full eligibility criteria
- Between 18 and 81 years old at the time of consent
- Fluency in English
- Medical history of cardiac arrest \>3 months ago
- Clinically elevated PTSD symptoms (Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) score ≥25)
- U.S. Resident
- Lifetime history of primary psychotic or bipolar disorders
- Current substance use disorder (moderate or severe in the past 6 months)
- Active suicidal ideation with some intent to act in past 12 months, and/or suicide attempt in past 24 months
- Substantial cognitive impairment (Mini Mental Status Exam (MMSE) score \<25)
- Initiation of new psychotropic medication \<3 months ago
- Non-cardiac etiology of CA (drowning, bleeding, trauma, drug overdose, etc)
- Terminal illness with life expectancy \<1 year
- Concurrent psychotherapy for PTSD
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 81 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.